Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA, as represented by th”

2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,147
Index total 30,257
Page 40 / 90

Quick answer

This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,147 results for “THE UNITED STATES OF AMERICA, as represented by th” · 30,257 patents in full index Clear search

  1. US 9394316

    Inhibitors of the plasmodial surface anion channel as antimalarials

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  2. US 9394352

    Immunogenic POTE peptides and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  3. US 9394364

    Human monoclonal antibodies specific for glypican-3 and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  4. US 9388222

    Modified Pseudomonas exotoxin A

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  5. US 9382311

    HIV-1 broadly neutralizing antibodies

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted

  6. US 9370559

    Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1

    The United States of America, as represented by the Secretary, Department of Heath Services · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted

  7. US 9364448

    Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted

  8. US 9364557

    Fold-back diabody diphtheria toxin immunotoxin and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted

  9. US 9359418

    Inhibitors of the T cell-specific alternative p38 activation pathway and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  10. US 9359447

    Anti-mesothelin chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  11. US 9358285

    Granulysin in immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  12. US 9353353

    Virus-like particles (VLPs) prepared from chikungunya virus structural proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 31, 2016 · Expires May 26, 2036

    granted

  13. US 9352032

    Live attenuated antigenically marked classical swine fever vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted May 31, 2016 · Expires May 26, 2036

    granted

  14. US 9345748

    Anti-SSX-2 T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 24, 2016 · Expires May 19, 2036

    granted

  15. US 9346859

    Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 24, 2016 · Expires May 19, 2036

    granted

  16. US 9341619

    Hyposialylation disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 17, 2016 · Expires May 12, 2036

    granted

  17. US 9333251

    Vaccine for protection against Shigella sonnei disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 10, 2016 · Expires May 5, 2036

    granted

  18. US 9334246

    Substituted triazines for malaria treatment and chemoprophylaxis

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted May 10, 2016 · Expires May 5, 2036

    granted

  19. US 9326992

    Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  20. US 9328391

    Cloning and expression of HIV-1 DNA

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  21. US 9326950

    Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  22. US 9328142

    Lipopeptide inhibitors of RAS oncoproteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  23. US 9320789

    Combinations of gene deletions for live attenuated shigella vaccine strains

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  24. US 9321834

    Anti-malarial compositions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.